LEXICON PHARMACEUTICALS, INC. Stock Issued During Period, Shares, Conversion of Convertible Securities
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Stock Issued During Period, Shares, Conversion of Convertible Securities of 20.42 million shares for the 1-month period ending 2026-04-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2026-08-06
- 2026-04-30: Stock Issued During Period, Shares, Conversion of Convertible Securities 1 month 20.42M shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities 1 month |
|---|---|
| 2026-04-30 | 20.42M shares 10-Q · filed 2026-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |